Relation between metformin treatment and the development of hyperlactacidemia at the emergency room;Relação entre o tratamento com metformina e o desenvolvimento de hiperlactacidemia no serviço de urgência

Acta Medica Portuguesa

Volumn 27, Issue 2, 2014, Pages 196-203

  Guelho, Daniela ^a   Paiva, Isabel ^a   Carrilho, Francisco ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Diabetes mellitus; Emergency service; Hospital; Lactates; Metformin; Portugal; Type 2

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

ARTICLE; BLOOD GAS ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC PATIENT; EMERGENCY WARD; HOSPITALIZATION; HUMAN; HYPERLACTATEMIA; LACTATE BLOOD LEVEL; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREVALENCE; RISK; AGED; CHEMICALLY INDUCED; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; EMERGENCY HEALTH SERVICE; FEMALE; MALE;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; HYPERLACTATEMIA; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; PREVALENCE; RISK;

EID: 84899996638     PISSN: 0870399X     EISSN: 16460758     Source Type: Journal    
DOI: 10.20344/amp.4071     Document Type: Article

References (20)

1. Qaseem A, Humphrey LL, Sweet DE, Starkey M, Shekelle P. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2012;156:218-31.
2. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577-1576.
3. Standards of medical care in diabetes--2012. Diabetes Care. 2012;35:S11-S63.
4. Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grun-berger G, et al. Statement by an American Association of Clinical En-docrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract. 2009;15:540-259.
5. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin Sci. 2012;122:253-270.
6. Kreisberg RA. Lactate homeostasis and lactic acidosis. Ann Intern Med. 1980;92:227-237.
7. Lalau JD. Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf. 2010;33:727-740.
8. Perrone J, Phillips C, Gaieski D. Occult metformin toxicity in three patients with profound lactic acidosis. J Emerg Med. 2011;40:271-275.
9. Liu F, Lu JX, Tang JL, Li L, Lu HJ, Hou XH, et al. Relationship of plasma creatinine and lactic acid in type 2 diabetic patients without renal dysfunction. Chin Med J. 2009;122:2547-2553.
10. Franzetti I, Paolo D, Marco G, Emanuela M, Elisabetta Z, Renato U. Possible synergistic effect of metformin and enalapril on the development of hyperkaliemic lactic acidosis. Diabetes Res Clin Pract. 1997;38:173-176.
11. Chan NN, Fauvel NJ, Feher MD. Non-steroidal anti-inflammatory drugs and metformin: a cause for concern? Lancet. 1998;352:201.
12. Nichol AD, Egi M, Pettila V, Bellomo R, French C, Hart G, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Crit Care. 2010;14:R25.
13. Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: a systematic review. Scand J Trauma Resusc Emerg Med. 2011;19:74.
14. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab.1996;81:4059-4067.
15. Crawford SO, Ambrose MS, Hoogeveen RC, Brancati FL, Ballantyne CM, Young JH. Association of lactate with blood pressure before and after rapid weight loss. Am J Hypertens. 2008;21:1337-1342.
16. Pepper GM, Schwartz M. Lactic acidosis associated with Glucophage use in a man with normal renal and hepatic function. Diabetes Care. 1997;20:232-233.
17. Bruijstens LA, van Luin M, Buscher-Jungerhans PM, Bosch FH. Reality of severe metformin-induced lactic acidosis in the absence of chronic renal impairment. Neth J Med. 2008;66:185-190.
18. Davis TM, Jackson D, Davis WA, Bruce DG, Chubb P. The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study. Br J Clin Pharmacol. 2001;52:137-144.
19. Martin JH, Fay MF, Ungerer JP. EGFR-use beyond the evidence. Med J Aust. 2009;190:197-199.
20. Ekström N, Schiöler L, Svensson AM, Eeg-Olofsson K, Miao Jonasson J, Zethelius B, et al. Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open. 2012;2: pii: e001076.